CliffBio
small molecule

CLINOLIPID 20%

OLIVE OIL; SOYBEAN OIL

Loss of exclusivityApril 2027FDA regulatory exclusivity expiry
CompanyBaxter Healthcare Corp →View the full company profile on CliffBio

Drug detail

Brand nameCLINOLIPID 20%
Active ingredientOLIVE OIL; SOYBEAN OIL
Strength16%(160GM/1000ML);4% (40GM/1000ML)
Dosage formEMULSION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalOctober 2013
Marketing statusRX

Regulatory exclusivity

CodeExpires
NPPApril 2027

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

CLINOLIPID 20% patent cliff — loss of exclusivity April 2027 | CliffBio